To Study the Safety and Efficacy of Autologous Bone Marrow Stem Cells in Patients With Spinal Cord Injury (ABSCI)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01730183|
Recruitment Status : Unknown
Verified November 2012 by Yashbir Dewan, Max Institute of Neurosciences.
Recruitment status was: Recruiting
First Posted : November 21, 2012
Last Update Posted : November 21, 2012
Max Institute of Neurosciences
Information provided by (Responsible Party):
Yashbir Dewan, Max Institute of Neurosciences
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||November 2014|
|Estimated Study Completion Date :||November 2014|
Geffner LF, Santacruz P, Izurieta M, Flor L, Maldonado B, Auad AH, Montenegro X, Gonzalez R, Silva F. Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplant. 2008;17(12):1277-93.